Cholesterol lowering and ezetimibe. [N Engl J Med. 2008]

Cited by 4 PubMed Central articles

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.
Yamaoka-Tojo M, Tojo T, Kosugi R, Hatakeyama Y, Yoshida Y, Machida Y, Aoyama N, Masuda T, Izumi T. Lipids Health Dis. 2009 Oct 12; 8:41. Epub 2009 Oct 12.

[Lipids Health Dis. 2009]
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.
Mani V, Muntner P, Gidding SS, Aguiar SH, El Aidi H, Weinshelbaum KB, Taniguchi H, van der Geest R, Reiber JH, Bansilal S, et al. J Cardiovasc Magn Reson. 2009 Apr 24; 11(1):10. Epub 2009 Apr 24.

[J Cardiovasc Magn Reson. 2009]
Fact or fiction: the need for independent pharmaceutical policy research.
Keyhani S, Federman A. J Gen Intern Med. 2009 May; 24(5):692-4.

[J Gen Intern Med. 2009]
» See all...

Lovastatin (Altoprev®, Mevacor®, Advicor® (as a combination product containing Niacin and Lovastatin))
Lovastatin is used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. Lovastatin is in a class of medications...
Simvastatin (Zocor®, Simcor® (as a combination product containing Niacin and Simvastatin), Vytorin® (as a combination product containing Ezetimibe and Simvastatin))
Simvastatin is used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in your blood. Simvastatin is in a class of medicati...
Ezetimibe (Zetia®, Vytorin® (as a combination product containing Ezetimibe and Simvastatin))
Ezetimibe is used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. It may be used alone or in combination w...
Source: AHFS Consumer Medication Information

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.